Skip to main content
Toggle navigation
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Red Recording
Sig Meeting
Like
Tweet
Print
Eric Cohen, MD
AbbVie
Poster(s):
(T 5) Weight Loss With Atogepant Versus Topiramate: Post hoc Analysis of the Head-to-Head TEMPLE Trial
(T 02) Long-Term Safety, Tolerability, and Efficacy of Atogepant for the Preventive Treatment of Migraine: Final Results from a Phase 3, Open-Label, 156-Week, Long-Term Safety Extension Study
(T 13) Blood Pressure Changes With Atogepant in Overweight and Obese Persons With Migraine and Baseline Hypertension: Interim Analysis of a Phase 3, Multicenter, Open-label, 156-Week Extension Study
